FDCDDQ
AUPH icon

Federation des caisses Desjardins du Quebec’s Aurinia Pharmaceuticals AUPH Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$359 – 2668
2024
Q4 		$359 Hold
40
– – ﹤0.01% 2418
2024
Q3 		$293 Hold
40
– – ﹤0.01% 2439
2024
Q2 		$228 Hold
40
– – ﹤0.01% 2320
2024
Q1 		$200 Sell
40
-200
-83% -$1.36K ﹤0.01% 2303
2023
Q4 		$2.16K Hold
240
– – ﹤0.01% 2054
2023
Q3 		$1.86K Hold
240
– – ﹤0.01% 2084
2023
Q2 		$2.32K Hold
240
– – ﹤0.01% 2043
2023
Q1 		$2.63K Hold
240
– – ﹤0.01% 2043
2022
Q4 		$1.04K Hold
240
– – ﹤0.01% 2278
2022
Q3 		$1.8K Hold
240
– – ﹤0.01% 2281
2022
Q2 		$2.41K Hold
240
– – ﹤0.01% 2282
2022
Q1 		$2.97K Buy
240
+200
+500% +$3.09K ﹤0.01% 2310
2021
Q4 		$915 Sell
40
-2,153
-98% -$51K ﹤0.01% 2422
2021
Q3 		$48.5K Sell
2,193
-300
-12% -$4.76K ﹤0.01% 1610
2021
Q2 		$32.2K Buy
2,493
+300
+14% +$3.82K ﹤0.01% 1728
2021
Q1 		$28.4K Hold
2,193
– – ﹤0.01% 1715
2020
Q4 		$29.9K Hold
2,193
– – ﹤0.01% 1639
2020
Q3 		$32K Sell
2,193
-1
-0% -$14 ﹤0.01% 1360
2020
Q2 		$35.2K Buy
2,194
+1
+0% +$16 ﹤0.01% 1304
2020
Q1 		$31.4K Buy
2,193
+780
+55% +$13.8K ﹤0.01% 1389
2019
Q4 		$28.3K Sell
1,413
-800
-36% -$7.37K ﹤0.01% 1654
2019
Q3 		$11.8K Hold
2,213
– – ﹤0.01% 1781
2019
Q2 		$14K Hold
2,213
– – ﹤0.01% 1766
2019
Q1 		$14.2K Sell
2,213
-3,000
-58% -$19.9K ﹤0.01% 1584
2018
Q4 		$34K Sell
5,213
-46
-0.9% -$265 ﹤0.01% 1378
2018
Q3 		$33.4K Hold
5,259
– – ﹤0.01% 1445
2018
Q2 		$28.4K Hold
5,259
– – ﹤0.01% 1480
2018
Q1 		$27.3K Buy
5,259
+1,370
+35% +$7.33K ﹤0.01% 1489
2017
Q4 		$17.7K Buy
3,889
+3,800
+4,270% +$21.1K ﹤0.01% 1597
2017
Q3 		$556 Hold
89
– – ﹤0.01% 2024
2017
Q2 		$544 Hold
89
– – ﹤0.01% 2088
2017
Q1 		$651 Buy
+89
New +$411 ﹤0.01% 1719

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's AUPH Position: Q1 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2025, closing a stake of 40 shares — an estimated $359 sold.

Federation des caisses Desjardins du Quebec first reported a position in AUPH in Q1 2017 and held it in 32 quarters. The position peaked at $48.5K in Q3 2021. 214 funds tracked by Wall St. Rank hold AUPH as of Q1 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Aurinia Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 40 Aurinia Pharmaceuticals shares in Q1 2025, an estimated $359.
  • Federation des caisses Desjardins du Quebec first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 32 quarters.
  • Federation des caisses Desjardins du Quebec's Aurinia Pharmaceuticals position peaked at $48.5K in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2025, filed 15 May 2025.